| Entry |
|
|---|
| Name |
Nimustine hydrochloride;
ACNU
|
|---|
| Formula |
C9H13ClN6O2. HCl
|
|---|
| Exact mass |
308.0555
|
|---|
| Mol weight |
309.1525
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01A ALKYLATING AGENTS
L01AD Nitrosoureas
L01AD06 Nimustine
D01059 Nimustine hydrochloride (JAN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
42 Antineoplastics
421 Alkylating agents
4219 Others
D01059 Nimustine hydrochloride (JAN)
Drug groups [BR:br08330]
Antineoplastic
DG01677 Alkylating agent
DG01724 Nitrosourea
DG00679 Nimustine
D01059 Nimustine hydrochloride
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 19
1 C8y C 19.3200 -19.5300
2 N5x N 19.3200 -18.1300
3 C8y C 20.5100 -17.4300
4 C8y C 21.7000 -18.1300
5 C8x C 21.7000 -19.5300
6 N5x N 20.5100 -20.2300
7 C1a C 18.0600 -20.2300
8 N1a N 20.5100 -16.0300
9 C1b C 22.9600 -17.4300
10 N1b N 24.1500 -18.1300
11 C5a C 25.3400 -17.4300
12 O5a O 25.3400 -16.0300
13 N1c N 26.6000 -18.1300
14 C1b C 27.7900 -17.4300
15 C1b C 28.9800 -18.1300
16 X Cl 30.1700 -17.5000
17 N2b N 26.6000 -19.5300
18 O3a O 25.3400 -20.2300
19 X Cl 33.8100 -17.6400
BOND 18
1 2 3 1
2 9 10 1
3 3 4 2
4 10 11 1
5 4 5 1
6 11 12 2
7 5 6 2
8 11 13 1
9 6 1 1
10 13 14 1
11 14 15 1
12 1 7 1
13 15 16 1
14 13 17 1
15 3 8 1
16 1 2 2
17 4 9 1
18 17 18 2
|
|---|
